A mutation in the 3′ region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance

被引:36
作者
Harrigan, PR
Salim, M
Stammers, DK
Wynhoven, B
Brumme, ZL
McKenna, P
Larder, B
Kemp, SD
机构
[1] BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
[2] Virco United Kingdom Ltd, Cambridge, England
[3] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England
[4] Virco NV, Mechelen, Belgium
关键词
D O I
10.1128/JVI.76.13.6836-6840.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Y318F substitution in the 3' region of human immunodeficiency virus type I (HIV-1) reverse transcriptase (RT) has been linked to normucleoside RT inhibitor (NNRTI) resistance in vitro. A systematic search of a large phenotypic-genotypic database (Virco) linked the Y318F substitution with a >10-fold decrease in NNRTI susceptibility in >85% of clinically derived isolates. There was a significant association between Y318F and use of delavirdine (P = 10(-11)) and nevirapine (P = 10(-6)) but not efavirenz (P = 0.3). Site-directed HIV-1 Y318F mutants in an HXB2 background displayed 42-fold-decreased susceptibility to delavirdine but <3-fold-decreased susceptibility to nevirapine or efavirenz. Combinations of Y318F with K103N, Y181C, or both resulted in decreased efavirenz susceptibility of 43-, 3.3-, and 84-fold, respectively, as well as >100- and >60-fold decreases in delavirdine and nevirapine susceptibility, respectively. These results indicate the importance of the Y318F substitution in HIV-1 drug resistance.
引用
收藏
页码:6836 / 6840
页数:5
相关论文
共 19 条
[11]   Antiretroviral drug resistance testing in adult HIV-1 infection -: Recommendations of an International AIDS Society-USA panel [J].
Hirsch, MS ;
Brun-Vézinet, F ;
D'Aquila, RT ;
Hammer, SM ;
Johnson, VA ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Clotet, B ;
Conway, B ;
Demeter, LM ;
Vella, S ;
Jacobsen, DM ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2417-2426
[12]   Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors [J].
Hopkins, AL ;
Ren, JS ;
Esnouf, RM ;
Willcox, BE ;
Jones, EY ;
Ross, C ;
Miyasaka, T ;
Walker, RT ;
Tanaka, H ;
Stammers, DK ;
Stuart, DI .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (08) :1589-1600
[13]   RECOMBINANT VIRUS ASSAY - A RAPID, PHENOTYPIC ASSAY FOR ASSESSMENT OF DRUG SUSCEPTIBILITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES [J].
KELLAM, P ;
LARDER, BA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (01) :23-30
[14]   CONVERGENT COMBINATION THERAPY CAN SELECT VIABLE MULTIDRUG-RESISTANT HIV-1 IN-VITRO [J].
LARDER, BA ;
KELLAM, P ;
KEMP, SD .
NATURE, 1993, 365 (6445) :451-453
[15]   QUANTITATIVE DETECTION OF HIV-1 DRUG-RESISTANCE MUTATIONS BY AUTOMATED DNA-SEQUENCING [J].
LARDER, BA ;
KOHLI, A ;
KELLAM, P ;
KEMP, SD ;
KRONICK, M ;
HENFREY, RD .
NATURE, 1993, 365 (6447) :671-673
[16]   Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase [J].
Pelemans, H ;
Esnouf, RM ;
Jonckheere, H ;
De Clercq, E ;
Balzarini, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) :34234-34239
[17]   Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase [J].
Ren, J ;
Milton, J ;
Weaver, KL ;
Short, SA ;
Stuart, DI ;
Stammers, DK .
STRUCTURE, 2000, 8 (10) :1089-1094
[18]   HIGH-RESOLUTION STRUCTURES OF HIV-1 RT FROM 4 RT-INHIBITOR COMPLEXES [J].
REN, JS ;
ESNOUF, R ;
GARMAN, E ;
SOMERS, D ;
ROSS, C ;
KIRBY, I ;
KEELING, J ;
DARBY, G ;
JONES, Y ;
STUART, D ;
STAMMERS, D .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (04) :293-302
[19]   STRUCTURE OF THE BINDING-SITE FOR NONNUCLEOSIDE INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
SMERDON, SJ ;
JAGER, J ;
WANG, J ;
KOHLSTAEDT, LA ;
CHIRINO, AJ ;
FRIEDMAN, JM ;
RICE, PA ;
STEITZ, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3911-3915